<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Drug Development Acceleration &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/drug-development-acceleration/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 04:21:46 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Drug Development Acceleration &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Analyzing Phase 1 Oncology Trial Expansion Cohorts</title>
		<link>https://bioengineer.org/analyzing-phase-1-oncology-trial-expansion-cohorts/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 04:21:36 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical trial design]]></category>
		<category><![CDATA[Clinical Trial Innovation]]></category>
		<category><![CDATA[Drug Development Acceleration]]></category>
		<category><![CDATA[Expansion Cohorts]]></category>
		<category><![CDATA[Patient Population Diversity]]></category>
		<category><![CDATA[Phase 1 Oncology Trials]]></category>
		<category><![CDATA[systematic review]]></category>
		<guid isPermaLink="false">https://bioengineer.org/analyzing-phase-1-oncology-trial-expansion-cohorts/</guid>

					<description><![CDATA[In a transformative exploration of oncology trials, researchers are recalibrating the boundaries of early-phase studies through the application of expansion cohorts. The use of these cohorts, as articulated in the recent systematic review by Herrero Colomina, Hu, and Dinizulu, delineates an emerging trend in Phase 1 clinical trials. Expanding the scope of these trials allows [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318716</post-id>	</item>
	</channel>
</rss>
